Literature DB >> 1975171

Characterization of beta-adrenoceptors on rat skeletal muscle cells grown in vitro.

M H Disatnik1, S R Sampson, A Shainberg.   

Abstract

The binding properties of an hydrophilic beta-adrenergic receptor radioligand, (-)[3H](4-(3-tert-butylamino-2-hydroxypropoxy)-benzimidazolo-2-one ); ([3H]CGP-12177), were investigated in rat skeletal muscle cells in culture. The binding of [3H]CGP-12177 at 25 degrees was saturable, reversible and of high affinity (Kd = 1.3 +/- 0.3 nM). The maximal number of [3H]CGP-12177 binding sites was 30.6 +/- 3.2 fmol/dish (34 +/- 3.5 fmol/mg protein). beta-Adrenergic agonists and antagonists inhibited [3H]CGP-12177 binding. The competing ligand inhibition binding is a typical one for beta 2-adrenoceptors. The increase in beta-adrenoceptors was independent of cell fusion. Amiodarone (10(-5) M) decreased the beta-adrenoceptor number in skeletal muscle cells differentiated in vitro by 48%, while the affinity for [3H]CGP-12177 was not affected.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1975171     DOI: 10.1016/0006-2952(90)90491-3

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  3 in total

1.  Effect of electrical stimulation on beta-adrenergic receptor population and cyclic amp production in chicken and rat skeletal muscle cell cultures.

Authors:  R B Young; K Y Bridge; C J Strietzel
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-03       Impact factor: 2.416

2.  Classical and atypical binding sites for beta-adrenoceptor ligands and activation of adenylyl cyclase in bovine skeletal muscle and adipose tissue membranes.

Authors:  M N Sillence; M L Matthews
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

3.  beta-adrenergic receptor population is up-regulated by increased cyclic adenosine monophosphate concentration in chicken skeletal muscle cells in culture.

Authors:  R B Young; K Y Bridge; J R Vaughn
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000 Jul-Aug       Impact factor: 2.723

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.